Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-15 receptor subunit alpha (IL-15Rα) is a high-affinity receptor subunit that specifically binds to IL-15. It forms a heterotrimeric receptor complex with IL-2/IL-15Rβ (CD122) and the common γ chain (γc, CD132), which is essential for IL-15 signaling. IL-15Rα plays a crucial role in the proliferation and survival of memory CD8+ T-cells, the development and function of NK cells, NKT cells, and intraepithelial lymphocytes. Its unique sushi domain allows for extremely high-affinity binding to IL-15, making it an attractive therapeutic target for modulating immune responses in diseases such as cancer and autoimmunity. It can present IL-15 in cis or in trans.
Modulation of IL-15 signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-15 receptor subunit alpha (IL-15Rα).